Apple (AAPL) 10-Q 2 Feb 24 2024 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares shares in Thousands	3 Months Ended
	Dec. 30, 2023	Jan. 19, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 30, 2023
Document Transition Report	false
Entity File Number	001-36743
Entity Registrant Name	Apple Inc.
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	94-2404110
Entity Address, Address Line One	One Apple Park Way
Entity Address, City or Town	Cupertino
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95014
City Area Code	408
Local Phone Number	996-1010
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		15,441,881
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000320193
Current Fiscal Year End Date	--09-28
Common Stock, $0.00001 par value per share
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $0.00001 par value per share
Trading Symbol	AAPL
Security Exchange Name	NASDAQ
0.000% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.000% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.875% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.625% Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	1.625% Notes due 2026
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
2.000% Notes due 2027
Entity Information [Line Items]
Title of 12(b) Security	2.000% Notes due 2027
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.375% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2029
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
3.050% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	3.050% Notes due 2029
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.500% Notes due 2031
Entity Information [Line Items]
Title of 12(b) Security	0.500% Notes due 2031
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
3.600% Notes due 2042
Entity Information [Line Items]
Title of 12(b) Security	3.600% Notes due 2042
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Net sales	$ 119,575	$ 117,154
Cost of sales	64,720	66,822
Gross margin	54,855	50,332
Operating expenses:
Research and development	7,696	7,709
Selling, general and administrative	6,786	6,607
Total operating expenses	14,482	14,316
Operating income	40,373	36,016
Other income/(expense), net	(50)	(393)
Income before provision for income taxes	40,323	35,623
Provision for income taxes	6,407	5,625
Net income	$ 33,916	$ 29,998
Earnings per share:
Basic (in dollars per share)	$ 2.19	$ 1.89
Diluted (in dollars per share)	$ 2.18	$ 1.88
Shares used in computing earnings per share:
Basic (in shares)	15,509,763	15,892,723
Diluted (in shares)	15,576,641	15,955,718
Products
Net sales	$ 96,458	$ 96,388
Cost of sales	58,440	60,765
Services
Net sales	23,117	20,766
Cost of sales	$ 6,280	$ 6,057

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 33,916	$ 29,998
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax	308	(14)
Change in unrealized gains/losses on derivative instruments, net of tax:
Change in fair value of derivative instruments	(531)	(988)
Adjustment for net (gains)/losses realized and included in net income	(823)	(1,766)
Total change in unrealized gains/losses on derivative instruments	(1,354)	(2,754)
Change in unrealized gains/losses on marketable debt securities, net of tax:
Change in fair value of marketable debt securities	3,045	900
Adjustment for net (gains)/losses realized and included in net income	75	65
Total change in unrealized gains/losses on marketable debt securities	3,120	965
Total other comprehensive income/(loss)	2,074	(1,803)
Total comprehensive income	$ 35,990	$ 28,195

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Dec. 30, 2023	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 40,760	$ 29,965
Marketable securities	32,340	31,590
Accounts receivable, net	23,194	29,508
Vendor non-trade receivables	26,908	31,477
Inventories	6,511	6,331
Other current assets	13,979	14,695
Total current assets	143,692	143,566
Non-current assets:
Marketable securities	99,475	100,544
Property, plant and equipment, net	43,666	43,715
Other non-current assets	66,681	64,758
Total non-current assets	209,822	209,017
Total assets	353,514	352,583
Current liabilities:
Accounts payable	58,146	62,611
Other current liabilities	54,611	58,829
Deferred revenue	8,264	8,061
Commercial paper	1,998	5,985
Term debt	10,954	9,822
Total current liabilities	133,973	145,308
Non-current liabilities:
Term debt	95,088	95,281
Other non-current liabilities	50,353	49,848
Total non-current liabilities	145,441	145,129
Total liabilities	279,414	290,437
Commitments and contingencies
Shareholders’ equity:
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,460,223 and 15,550,061 shares issued and outstanding, respectively	75,236	73,812
Retained earnings/(Accumulated deficit)	8,242	(214)
Accumulated other comprehensive loss	(9,378)	(11,452)
Total shareholders’ equity	74,100	62,146
Total liabilities and shareholders’ equity	$ 353,514	$ 352,583

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Dec. 30, 2023	Sep. 30, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	50,400,000,000	50,400,000,000
Common stock, shares issued (in shares)	15,460,223,000	15,550,061,000
Common stock, shares outstanding (in shares)	15,460,223,000	15,550,061,000

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common stock and additional paid-in capital	Retained earnings/(Accumulated deficit)	Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 24, 2022	$ 50,672	$ 64,849	$ (3,068)	$ (11,109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock withheld related to net share settlement of equity awards		(1,434)	(978)
Share-based compensation		2,984
Net income	29,998		29,998
Dividends and dividend equivalents declared			(3,712)
Common stock repurchased			(19,000)
Other comprehensive income/(loss)	(1,803)			(1,803)
Ending balances at Dec. 31, 2022	$ 56,727	66,399	3,240	(12,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.23
Beginning balances at Sep. 30, 2023	$ 62,146	73,812	(214)	(11,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock withheld related to net share settlement of equity awards		(1,660)	(1,018)
Share-based compensation		3,084
Net income	33,916		33,916
Dividends and dividend equivalents declared			(3,774)
Common stock repurchased	(20,500)		(20,668)
Other comprehensive income/(loss)	2,074			2,074
Ending balances at Dec. 30, 2023	$ 74,100	$ 75,236	$ 8,242	$ (9,378)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.24

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Statement of Cash Flows [Abstract]
Cash, cash equivalents and restricted cash, beginning balances	$ 30,737	$ 24,977
Operating activities:
Net income	33,916	29,998
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization	2,848	2,916
Share-based compensation expense	2,997	2,905
Other	(989)	(317)
Changes in operating assets and liabilities:
Accounts receivable, net	6,555	4,275
Vendor non-trade receivables	4,569	2,320
Inventories	(137)	(1,807)
Other current and non-current assets	(1,457)	(4,099)
Accounts payable	(4,542)	(6,075)
Other current and non-current liabilities	(3,865)	3,889
Cash generated by operating activities	39,895	34,005
Investing activities:
Purchases of marketable securities	(9,780)	(5,153)
Proceeds from maturities of marketable securities	13,046	7,127
Proceeds from sales of marketable securities	1,337	509
Payments for acquisition of property, plant and equipment	(2,392)	(3,787)
Other	(284)	(141)
Cash generated by/(used in) investing activities	1,927	(1,445)
Financing activities:
Payments for taxes related to net share settlement of equity awards	(2,591)	(2,316)
Payments for dividends and dividend equivalents	(3,825)	(3,768)
Repurchases of common stock	(20,139)	(19,475)
Repayments of term debt	0	(1,401)
Repayments of commercial paper, net	(3,984)	(8,214)
Other	(46)	(389)
Cash used in financing activities	(30,585)	(35,563)
Increase/(Decrease) in cash, cash equivalents and restricted cash	11,237	(3,003)
Cash, cash equivalents and restricted cash, ending balances	41,974	21,974
Supplemental cash flow disclosure:
Cash paid for income taxes, net	$ 7,255	$ 828

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Preparation The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Form 10-K”). The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.

Revenue

Revenue	3 Months Ended
	Dec. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Net sales disaggregated by significant products and services for the three months ended December 30, 2023 and December 31, 2022 were as follows (in millions): Three Months Ended December 30, December 31, iPhone ® $ 69,702 $ 65,775 Mac ® 7,780 7,735 iPad ® 7,023 9,396 Wearables, Home and Accessories 11,953 13,482 Services 23,117 20,766 Total net sales $ 119,575 $ 117,154 Total net sales include $3.5 billion of revenue recognized in the three months ended December 30, 2023 that was included in deferred revenue as of September 30, 2023 and $3.4 billion of revenue recognized in the three months ended December 31, 2022 that was included in deferred revenue as of September 24, 2022. The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 10, “Segment Information and Geographic Data” for the three months ended December 30, 2023 and December 31, 2022, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales. As of December 30, 2023 and September 30, 2023, the Company had total deferred revenue of $12.5 billion and $12.1 billion, respectively. As of December 30, 2023, the Company expects 66% of total deferred revenue to be realized in less than a year, 26% within one-to-two years, 7% within two-to-three years and 1% in greater than three years.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Dec. 30, 2023
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table shows the computation of basic and diluted earnings per share for the three months ended December 30, 2023 and December 31, 2022 (net income in millions and shares in thousands): Three Months Ended December 30, December 31, Numerator: Net income $ 33,916 $ 29,998 Denominator: Weighted-average basic shares outstanding 15,509,763 15,892,723 Effect of dilutive share-based awards 66,878 62,995 Weighted-average diluted shares 15,576,641 15,955,718 Basic earnings per share $ 2.19 $ 1.89 Diluted earnings per share $ 2.18 $ 1.88 Approximately 89 million restricted stock units (“RSUs”) were excluded from the computation of diluted earnings per share for the three months ended December 31, 2022 because their effect would have been antidilutive.

Financial Instruments

Financial Instruments	3 Months Ended
	Dec. 30, 2023
Financial Instruments [Abstract]
Financial Instruments	Financial Instruments Cash, Cash Equivalents and Marketable Securities The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 30, 2023 and September 30, 2023 (in millions): December 30, 2023 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Marketable Cash $ 29,542 $ — $ — $ 29,542 $ 29,542 $ — $ — Level 1: Money market funds 2,000 — — 2,000 2,000 — — Mutual funds 448 35 (11) 472 — 472 — Subtotal 2,448 35 (11) 2,472 2,000 472 — Level 2 (1) : U.S. Treasury securities 24,041 12 (920) 23,133 7,303 4,858 10,972 U.S. agency securities 5,791 — (448) 5,343 243 98 5,002 Non-U.S. government securities 17,326 54 (675) 16,705 — 11,175 5,530 Certificates of deposit and time deposits 1,448 — — 1,448 1,119 329 — Commercial paper 1,361 — — 1,361 472 889 — Corporate debt securities 75,360 112 (3,964) 71,508 81 13,909 57,518 Municipal securities 562 — (14) 548 — 185 363 Mortgage- and asset-backed securities 22,369 53 (1,907) 20,515 — 425 20,090 Subtotal 148,258 231 (7,928) 140,561 9,218 31,868 99,475 Total (2) $ 180,248 $ 266 $ (7,939) $ 172,575 $ 40,760 $ 32,340 $ 99,475 September 30, 2023 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Cash $ 28,359 $ — $ — $ 28,359 $ 28,359 $ — $ — Level 1: Money market funds 481 — — 481 481 — — Mutual funds and equity securities 442 12 (26) 428 — 428 — Subtotal 923 12 (26) 909 481 428 — Level 2 (1) : U.S. Treasury securities 19,406 — (1,292) 18,114 35 5,468 12,611 U.S. agency securities 5,736 — (600) 5,136 36 271 4,829 Non-U.S. government securities 17,533 6 (1,048) 16,491 — 11,332 5,159 Certificates of deposit and time deposits 1,354 — — 1,354 1,034 320 — Commercial paper 608 — — 608 — 608 — Corporate debt securities 76,840 6 (5,956) 70,890 20 12,627 58,243 Municipal securities 628 — (26) 602 — 192 410 Mortgage- and asset-backed securities 22,365 6 (2,735) 19,636 — 344 19,292 Subtotal 144,470 18 (11,657) 132,831 1,125 31,162 100,544 Total (2) $ 173,752 $ 30 $ (11,683) $ 162,099 $ 29,965 $ 31,590 $ 100,544 (1) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data. (2) As of December 30, 2023 and September 30, 2023, total marketable securities included $13.9 billion and $13.8 billion, respectively, that were restricted from general use, related to the European Commission decision finding that Ireland granted state aid to the Company, and other agreements. The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of December 30, 2023 (in millions): Due after 1 year through 5 years $ 72,994 Due after 5 years through 10 years 9,368 Due after 10 years 17,113 Total fair value $ 99,475 Derivative Instruments and Hedging The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates. Foreign Exchange Rate Risk To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of December 30, 2023, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt–related foreign currency transactions is 19 years. The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies. Interest Rate Risk To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges. The notional amounts of the Company’s outstanding derivative instruments as of December 30, 2023 and September 30, 2023 were as follows (in millions): December 30, September 30, Derivative instruments designated as accounting hedges: Foreign exchange contracts $ 66,735 $ 74,730 Interest rate contracts $ 19,375 $ 19,375 Derivative instruments not designated as accounting hedges: Foreign exchange contracts $ 102,108 $ 104,777 The carrying amounts of the Company’s hedged items in fair value hedges as of December 30, 2023 and September 30, 2023 were as follows (in millions): December 30, September 30, Hedged assets/(liabilities): Current and non-current marketable securities $ 15,102 $ 14,433 Current and non-current term debt $ (18,661) $ (18,247) Accounts Receivable Trade Receivables The Company’s third-party cellular network carriers accounted for 34% and 41% of total trade receivables as of December 30, 2023 and September 30, 2023, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk. Vendor Non-Trade Receivables The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of December 30, 2023, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 50% and 20% . As of September 30, 2023, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 48% and 23%.

Condensed Consolidated Financia

Condensed Consolidated Financial Statement Details	3 Months Ended
	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Financial Statement Details	Condensed Consolidated Financial Statement Details The following table shows the Company’s condensed consolidated financial statement details as of December 30, 2023 and September 30, 2023 (in millions): Property, Plant and Equipment, Net December 30, September 30, Gross property, plant and equipment $ 116,176 $ 114,599 Accumulated depreciation (72,510) (70,884) Total property, plant and equipment, net $ 43,666 $ 43,715

Debt

Debt	3 Months Ended
	Dec. 30, 2023
Debt Disclosure [Abstract]
Debt	Debt Commercial Paper The Company issues unsecured short-term promissory notes pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of December 30, 2023 and September 30, 2023, the Company had $2.0 billion and $6.0 billion of commercial paper outstanding, respectively. The following table provides a summary of cash flows associated with the issuance and maturities of commercial paper for the three months ended December 30, 2023 and December 31, 2022 (in millions): Three Months Ended December 30, December 31, Maturities 90 days or less: Repayments of commercial paper, net $ (3,984) $ (5,569) Maturities greater than 90 days: Repayments of commercial paper — (2,645) Total repayments of commercial paper, net $ (3,984) $ (8,214) Term Debt As of December 30, 2023 and September 30, 2023, the Company had outstanding fixed-rate notes with varying maturities for an aggregate carrying amount of $106.0 billion and $105.1 billion, respectively (collectively the “Notes”). As of December 30, 2023 and September 30, 2023, the fair value of the Company’s Notes, based on Level 2 inputs, was $96.7 billion and $90.8 billion, respectively.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Dec. 30, 2023
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchase Program During the three months ended December 30, 2023, the Company repurchased 118 million shares of its common stock for $20.5 billion. The Company’s share repurchase program does not obligate the Company to acquire a minimum amount of shares. Under the program, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Dec. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Restricted Stock Units A summary of the Company’s RSU activity and related information for the three months ended December 30, 2023 is as follows: Number of RSUs (in thousands) Weighted-Average Aggregate Fair Value (in millions) Balance as of September 30, 2023 180,247 $ 135.91 RSUs granted 74,241 $ 171.58 RSUs vested (42,490) $ 110.75 RSUs canceled (3,026) $ 109.05 Balance as of December 30, 2023 208,972 $ 154.09 $ 40,233 The fair value as of the respective vesting dates of RSUs was $7.7 billion and $6.8 billion for the three months ended December 30, 2023 and December 31, 2022, respectively. Share-Based Compensation The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three months ended December 30, 2023 and December 31, 2022 (in millions): Three Months Ended December 30, December 31, Share-based compensation expense $ 2,997 $ 2,905 Income tax benefit related to share-based compensation expense $ (1,235) $ (1,178) As of December 30, 2023, the total unrecognized compensation cost related to outstanding RSUs was $27.4 billion, which the Company expects to recognize over a weighted-average period of 2.9 years.

Contingencies

Contingencies	3 Months Ended
	Dec. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.

Segment Information and Geograp

Segment Information and Geographic Data	3 Months Ended
	Dec. 30, 2023
Segment Reporting [Abstract]
Segment Information and Geographic Data	Segment Information and Geographic Data The following table shows information by reportable segment for the three months ended December 30, 2023 and December 31, 2022 (in millions): Three Months Ended December 30, December 31, Americas: Net sales $ 50,430 $ 49,278 Operating income $ 20,357 $ 17,864 Europe: Net sales $ 30,397 $ 27,681 Operating income $ 12,711 $ 10,017 Greater China: Net sales $ 20,819 $ 23,905 Operating income $ 8,622 $ 10,437 Japan: Net sales $ 7,767 $ 6,755 Operating income $ 3,819 $ 3,236 Rest of Asia Pacific: Net sales $ 10,162 $ 9,535 Operating income $ 4,579 $ 3,851 A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 30, 2023 and December 31, 2022 is as follows (in millions): Three Months Ended December 30, December 31, Segment operating income $ 50,088 $ 45,405 Research and development expense (7,696) (7,709) Other corporate expenses, net (2,019) (1,680) Total operating income $ 40,373 $ 36,016

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income	$ 33,916	$ 29,998

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 30, 2023
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Luca Maestri [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On November 11, 2023 and November 27, 2023, respectively, Luca Maestri, the Company’s Senior Vice President and Chief Financial Officer, and Katherine L. Adams, the Company’s Senior Vice President and General Counsel, each entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plans provide for the sale of all shares vested during the duration of the plans pursuant to certain equity awards granted to Mr. Maestri and Ms. Adams, respectively, excluding any shares withheld by the Company to satisfy income tax withholding and remittance obligations. Mr. Maestri’s plan will expire on December 31, 2024, and Ms. Adams’s plan will expire on November 1, 2024, subject to early termination for certain specified events set forth in the plans.
Name	Luca Maestri
Title	Senior Vice President and Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 11, 2023
Arrangement Duration	416 days
Katherine L. Adams [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On November 11, 2023 and November 27, 2023, respectively, Luca Maestri, the Company’s Senior Vice President and Chief Financial Officer, and Katherine L. Adams, the Company’s Senior Vice President and General Counsel, each entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plans provide for the sale of all shares vested during the duration of the plans pursuant to certain equity awards granted to Mr. Maestri and Ms. Adams, respectively, excluding any shares withheld by the Company to satisfy income tax withholding and remittance obligations. Mr. Maestri’s plan will expire on December 31, 2024, and Ms. Adams’s plan will expire on November 1, 2024, subject to early termination for certain specified events set forth in the plans.
Name	Katherine L. Adams
Title	Senior Vice President and General Counsel
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 27, 2023
Arrangement Duration	340 days

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Preparation	Basis of Presentation and Preparation The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Form 10-K”).
Fiscal Period	The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Fair Value Measurements	The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Dec. 30, 2023
Revenue from Contract with Customer [Abstract]
Net Sales Disaggregated by Significant Products and Services	Net sales disaggregated by significant products and services for the three months ended December 30, 2023 and December 31, 2022 were as follows (in millions): Three Months Ended December 30, December 31, iPhone ® $ 69,702 $ 65,775 Mac ® 7,780 7,735 iPad ® 7,023 9,396 Wearables, Home and Accessories 11,953 13,482 Services 23,117 20,766 Total net sales $ 119,575 $ 117,154

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Dec. 30, 2023
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table shows the computation of basic and diluted earnings per share for the three months ended December 30, 2023 and December 31, 2022 (net income in millions and shares in thousands): Three Months Ended December 30, December 31, Numerator: Net income $ 33,916 $ 29,998 Denominator: Weighted-average basic shares outstanding 15,509,763 15,892,723 Effect of dilutive share-based awards 66,878 62,995 Weighted-average diluted shares 15,576,641 15,955,718 Basic earnings per share $ 2.19 $ 1.89 Diluted earnings per share $ 2.18 $ 1.88

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Dec. 30, 2023
Financial Instruments [Abstract]
Cash, Cash Equivalents and Marketable Securities by Significant Investment Category	The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 30, 2023 and September 30, 2023 (in millions): December 30, 2023 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Marketable Cash $ 29,542 $ — $ — $ 29,542 $ 29,542 $ — $ — Level 1: Money market funds 2,000 — — 2,000 2,000 — — Mutual funds 448 35 (11) 472 — 472 — Subtotal 2,448 35 (11) 2,472 2,000 472 — Level 2 (1) : U.S. Treasury securities 24,041 12 (920) 23,133 7,303 4,858 10,972 U.S. agency securities 5,791 — (448) 5,343 243 98 5,002 Non-U.S. government securities 17,326 54 (675) 16,705 — 11,175 5,530 Certificates of deposit and time deposits 1,448 — — 1,448 1,119 329 — Commercial paper 1,361 — — 1,361 472 889 — Corporate debt securities 75,360 112 (3,964) 71,508 81 13,909 57,518 Municipal securities 562 — (14) 548 — 185 363 Mortgage- and asset-backed securities 22,369 53 (1,907) 20,515 — 425 20,090 Subtotal 148,258 231 (7,928) 140,561 9,218 31,868 99,475 Total (2) $ 180,248 $ 266 $ (7,939) $ 172,575 $ 40,760 $ 32,340 $ 99,475 September 30, 2023 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Cash $ 28,359 $ — $ — $ 28,359 $ 28,359 $ — $ — Level 1: Money market funds 481 — — 481 481 — — Mutual funds and equity securities 442 12 (26) 428 — 428 — Subtotal 923 12 (26) 909 481 428 — Level 2 (1) : U.S. Treasury securities 19,406 — (1,292) 18,114 35 5,468 12,611 U.S. agency securities 5,736 — (600) 5,136 36 271 4,829 Non-U.S. government securities 17,533 6 (1,048) 16,491 — 11,332 5,159 Certificates of deposit and time deposits 1,354 — — 1,354 1,034 320 — Commercial paper 608 — — 608 — 608 — Corporate debt securities 76,840 6 (5,956) 70,890 20 12,627 58,243 Municipal securities 628 — (26) 602 — 192 410 Mortgage- and asset-backed securities 22,365 6 (2,735) 19,636 — 344 19,292 Subtotal 144,470 18 (11,657) 132,831 1,125 31,162 100,544 Total (2) $ 173,752 $ 30 $ (11,683) $ 162,099 $ 29,965 $ 31,590 $ 100,544 (1) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data. (2) As of December 30, 2023 and September 30, 2023, total marketable securities included $13.9 billion and $13.8 billion, respectively, that were restricted from general use, related to the European Commission decision finding that Ireland granted state aid to the Company, and other agreements.
Non-Current Marketable Debt Securities by Contractual Maturity	The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of December 30, 2023 (in millions): Due after 1 year through 5 years $ 72,994 Due after 5 years through 10 years 9,368 Due after 10 years 17,113 Total fair value $ 99,475
Notional Amounts of Outstanding Derivative Instruments	The notional amounts of the Company’s outstanding derivative instruments as of December 30, 2023 and September 30, 2023 were as follows (in millions): December 30, September 30, Derivative instruments designated as accounting hedges: Foreign exchange contracts $ 66,735 $ 74,730 Interest rate contracts $ 19,375 $ 19,375 Derivative instruments not designated as accounting hedges: Foreign exchange contracts $ 102,108 $ 104,777
Carrying Amounts of Hedged Items in Fair Value Hedges	The carrying amounts of the Company’s hedged items in fair value hedges as of December 30, 2023 and September 30, 2023 were as follows (in millions): December 30, September 30, Hedged assets/(liabilities): Current and non-current marketable securities $ 15,102 $ 14,433 Current and non-current term debt $ (18,661) $ (18,247)

Condensed Consolidated Financ_2

Condensed Consolidated Financial Statement Details (Tables)	3 Months Ended
	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Property, Plant and Equipment, Net	The following table shows the Company’s condensed consolidated financial statement details as of December 30, 2023 and September 30, 2023 (in millions): Property, Plant and Equipment, Net December 30, September 30, Gross property, plant and equipment $ 116,176 $ 114,599 Accumulated depreciation (72,510) (70,884) Total property, plant and equipment, net $ 43,666 $ 43,715

Debt (Tables)

Debt (Tables)	3 Months Ended
	Dec. 30, 2023
Debt Disclosure [Abstract]
Summary of Cash Flows Associated with the Issuance and Maturities of Commercial Paper	The following table provides a summary of cash flows associated with the issuance and maturities of commercial paper for the three months ended December 30, 2023 and December 31, 2022 (in millions): Three Months Ended December 30, December 31, Maturities 90 days or less: Repayments of commercial paper, net $ (3,984) $ (5,569) Maturities greater than 90 days: Repayments of commercial paper — (2,645) Total repayments of commercial paper, net $ (3,984) $ (8,214)

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Dec. 30, 2023
Share-Based Payment Arrangement [Abstract]
Restricted Stock Unit Activity	A summary of the Company’s RSU activity and related information for the three months ended December 30, 2023 is as follows: Number of RSUs (in thousands) Weighted-Average Aggregate Fair Value (in millions) Balance as of September 30, 2023 180,247 $ 135.91 RSUs granted 74,241 $ 171.58 RSUs vested (42,490) $ 110.75 RSUs canceled (3,026) $ 109.05 Balance as of December 30, 2023 208,972 $ 154.09 $ 40,233
Summary of Share-Based Compensation Expense and the Related Income Tax Benefit	The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three months ended December 30, 2023 and December 31, 2022 (in millions): Three Months Ended December 30, December 31, Share-based compensation expense $ 2,997 $ 2,905 Income tax benefit related to share-based compensation expense $ (1,235) $ (1,178)

Segment Information and Geogr_2

Segment Information and Geographic Data (Tables)	3 Months Ended
	Dec. 30, 2023
Segment Reporting [Abstract]
Information by Reportable Segment	The following table shows information by reportable segment for the three months ended December 30, 2023 and December 31, 2022 (in millions): Three Months Ended December 30, December 31, Americas: Net sales $ 50,430 $ 49,278 Operating income $ 20,357 $ 17,864 Europe: Net sales $ 30,397 $ 27,681 Operating income $ 12,711 $ 10,017 Greater China: Net sales $ 20,819 $ 23,905 Operating income $ 8,622 $ 10,437 Japan: Net sales $ 7,767 $ 6,755 Operating income $ 3,819 $ 3,236 Rest of Asia Pacific: Net sales $ 10,162 $ 9,535 Operating income $ 4,579 $ 3,851
Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations	A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 30, 2023 and December 31, 2022 is as follows (in millions): Three Months Ended December 30, December 31, Segment operating income $ 50,088 $ 45,405 Research and development expense (7,696) (7,709) Other corporate expenses, net (2,019) (1,680) Total operating income $ 40,373 $ 36,016

Revenue - Net Sales Disaggregat

Revenue - Net Sales Disaggregated by Significant Products and Services (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Net sales	$ 119,575	$ 117,154
iPhone
Disaggregation of Revenue [Line Items]
Net sales	69,702	65,775
Mac
Disaggregation of Revenue [Line Items]
Net sales	7,780	7,735
iPad
Disaggregation of Revenue [Line Items]
Net sales	7,023	9,396
Wearables, Home and Accessories
Disaggregation of Revenue [Line Items]
Net sales	11,953	13,482
Services
Disaggregation of Revenue [Line Items]
Net sales	$ 23,117	$ 20,766

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Billions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue recognized that was included in deferred revenue at the beginning of the period	$ 3.5	$ 3.4
Total deferred revenue	$ 12.5		$ 12.1

Revenue - Deferred Revenue, Exp

Revenue - Deferred Revenue, Expected Timing of Realization (Details)	Dec. 30, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-12-31
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	66%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-12-29
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	26%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-12-28
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	7%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-12-27
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	1%
Deferred revenue, expected timing of realization, period

Earnings Per Share - Computatio

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Numerator:
Net income	$ 33,916	$ 29,998
Denominator:
Weighted-average basic shares outstanding (in shares)	15,509,763	15,892,723
Effect of dilutive share-based awards (in shares)	66,878	62,995
Weighted-average diluted shares (in shares)	15,576,641	15,955,718
Basic earnings per share (in dollars per share)	$ 2.19	$ 1.89
Diluted earnings per share (in dollars per share)	$ 2.18	$ 1.88

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) shares in Millions	3 Months Ended
	Dec. 31, 2022 shares
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Restricted stock units excluded from the computation of diluted earnings per share because their effect would have been antidilutive (in shares)	89

Financial Instruments - Cash, C

Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Millions	Dec. 30, 2023	Sep. 30, 2023
Marketable Securities [Line Items]
Cash, Cash Equivalents and Marketable Securities, Adjusted Cost	$ 180,248	$ 173,752
Cash Equivalents and Marketable Securities, Unrealized Gains	266	30
Cash Equivalents and Marketable Securities, Unrealized Losses	(7,939)	(11,683)
Cash, Cash Equivalents and Marketable Securities, Fair Value	172,575	162,099
Cash and Cash Equivalents	40,760	29,965
Current Marketable Securities	32,340	31,590
Non-Current Marketable Securities	99,475	100,544
Total marketable securities that were restricted from general use	13,900	13,800
Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	2,448	923
Marketable Securities, Equity, Unrealized Gains	35	12
Marketable Securities, Equity, Unrealized Losses	(11)	(26)
Marketable Securities, Equity, Fair Value	2,472	909
Cash and Cash Equivalents	2,000	481
Current Marketable Securities	472	428
Non-Current Marketable Securities	0	0
Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	148,258	144,470
Marketable Securities, Debt, Unrealized Gains	231	18
Marketable Securities, Debt, Unrealized Losses	(7,928)	(11,657)
Marketable Securities, Debt, Fair Value	140,561	132,831
Cash and Cash Equivalents	9,218	1,125
Current Marketable Securities	31,868	31,162
Non-Current Marketable Securities	99,475	100,544
Cash
Marketable Securities [Line Items]
Cash	29,542	28,359
Cash and Cash Equivalents	29,542	28,359
Current Marketable Securities	0	0
Non-Current Marketable Securities	0	0
Money market funds | Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	2,000	481
Marketable Securities, Equity, Unrealized Gains	0	0
Marketable Securities, Equity, Unrealized Losses	0	0
Marketable Securities, Equity, Fair Value	2,000	481
Cash and Cash Equivalents	2,000	481
Current Marketable Securities	0	0
Non-Current Marketable Securities	0	0
Mutual funds | Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	448
Marketable Securities, Equity, Unrealized Gains	35
Marketable Securities, Equity, Unrealized Losses	(11)
Marketable Securities, Equity, Fair Value	472
Cash and Cash Equivalents	0
Current Marketable Securities	472
Non-Current Marketable Securities	0
Mutual funds and equity securities | Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost		442
Marketable Securities, Equity, Unrealized Gains		12
Marketable Securities, Equity, Unrealized Losses		(26)
Marketable Securities, Equity, Fair Value		428
Cash and Cash Equivalents		0
Current Marketable Securities		428
Non-Current Marketable Securities		0
U.S. Treasury securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	24,041	19,406
Marketable Securities, Debt, Unrealized Gains	12	0
Marketable Securities, Debt, Unrealized Losses	(920)	(1,292)
Marketable Securities, Debt, Fair Value	23,133	18,114
Cash and Cash Equivalents	7,303	35
Current Marketable Securities	4,858	5,468
Non-Current Marketable Securities	10,972	12,611
U.S. agency securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	5,791	5,736
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	(448)	(600)
Marketable Securities, Debt, Fair Value	5,343	5,136
Cash and Cash Equivalents	243	36
Current Marketable Securities	98	271
Non-Current Marketable Securities	5,002	4,829
Non-U.S. government securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	17,326	17,533
Marketable Securities, Debt, Unrealized Gains	54	6
Marketable Securities, Debt, Unrealized Losses	(675)	(1,048)
Marketable Securities, Debt, Fair Value	16,705	16,491
Cash and Cash Equivalents	0	0
Current Marketable Securities	11,175	11,332
Non-Current Marketable Securities	5,530	5,159
Certificates of deposit and time deposits | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	1,448	1,354
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	0	0
Marketable Securities, Debt, Fair Value	1,448	1,354
Cash and Cash Equivalents	1,119	1,034
Current Marketable Securities	329	320
Non-Current Marketable Securities	0	0
Commercial paper | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	1,361	608
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	0	0
Marketable Securities, Debt, Fair Value	1,361	608
Cash and Cash Equivalents	472	0
Current Marketable Securities	889	608
Non-Current Marketable Securities	0	0
Corporate debt securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	75,360	76,840
Marketable Securities, Debt, Unrealized Gains	112	6
Marketable Securities, Debt, Unrealized Losses	(3,964)	(5,956)
Marketable Securities, Debt, Fair Value	71,508	70,890
Cash and Cash Equivalents	81	20
Current Marketable Securities	13,909	12,627
Non-Current Marketable Securities	57,518	58,243
Municipal securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	562	628
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	(14)	(26)
Marketable Securities, Debt, Fair Value	548	602
Cash and Cash Equivalents	0	0
Current Marketable Securities	185	192
Non-Current Marketable Securities	363	410
Mortgage- and asset-backed securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	22,369	22,365
Marketable Securities, Debt, Unrealized Gains	53	6
Marketable Securities, Debt, Unrealized Losses	(1,907)	(2,735)
Marketable Securities, Debt, Fair Value	20,515	19,636
Cash and Cash Equivalents	0	0
Current Marketable Securities	425	344
Non-Current Marketable Securities	$ 20,090	$ 19,292

Financial Instruments - Non-Cur

Financial Instruments - Non-Current Marketable Debt Securities by Contractual Maturity (Details) $ in Millions	Dec. 30, 2023 USD ($)
Fair value of non-current marketable debt securities by contractual maturity
Due after 1 year through 5 years	$ 72,994
Due after 5 years through 10 years	9,368
Due after 10 years	17,113
Total fair value	$ 99,475

Financial Instruments - Additio

Financial Instruments - Additional Information (Details) - Vendor	3 Months Ended	12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023
Trade receivables | Credit concentration risk | Cellular network carriers
Financial Instruments [Line Items]
Concentration risk, percentage	34%	41%
Non-trade receivables | Credit concentration risk
Financial Instruments [Line Items]
Number of vendors that individually represented 10% or more of total vendor non-trade receivables	2	2
Non-trade receivables | Credit concentration risk | Vendor one
Financial Instruments [Line Items]
Concentration risk, percentage	50%	48%
Non-trade receivables | Credit concentration risk | Vendor two
Financial Instruments [Line Items]
Concentration risk, percentage	20%	23%
Hedges of foreign currency exposure associated with revenue and inventory purchases
Financial Instruments [Line Items]
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions	12 months
Hedges of foreign currency exposure associated with term debt
Financial Instruments [Line Items]
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions	19 years

Financial Instruments - Notiona

Financial Instruments - Notional Amounts of Derivative Instruments (Details) - USD ($) $ in Millions	Dec. 30, 2023	Sep. 30, 2023
Derivatives designated as accounting hedges | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	$ 66,735	$ 74,730
Derivatives designated as accounting hedges | Interest rate contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	19,375	19,375
Derivatives not designated as accounting hedges | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	$ 102,108	$ 104,777

Financial Instruments - Derivat

Financial Instruments - Derivative Instruments Designated as Fair Value Hedges and Related Hedged Items (Details) - USD ($) $ in Millions	Dec. 30, 2023	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Carrying amount of hedged marketable securities	$ 15,102	$ 14,433
Hedged asset, statement of financial position [Extensible Enumeration]	Marketable securities, Marketable securities	Marketable securities, Marketable securities
Carrying amount of hedged term debt	$ (18,661)	$ (18,247)
Hedged liability, statement of financial position [Extensible Enumeration]	Term debt, Term debt	Term debt, Term debt

Condensed Consolidated Financ_3

Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions	Dec. 30, 2023	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Gross property, plant and equipment	$ 116,176	$ 114,599
Accumulated depreciation	(72,510)	(70,884)
Total property, plant and equipment, net	$ 43,666	$ 43,715

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($) $ in Millions	Dec. 30, 2023	Sep. 30, 2023
Debt Instrument [Line Items]
Commercial paper	$ 1,998	$ 5,985
Fixed-rate notes, aggregate carrying amount	106,000	105,100
Commercial paper
Debt Instrument [Line Items]
Commercial paper	2,000	6,000
Level 2
Debt Instrument [Line Items]
Fixed-rate notes, aggregate fair value	$ 96,700	$ 90,800

Debt - Summary of Cash Flows As

Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Maturities 90 days or less:
Repayments of commercial paper, net	$ (3,984)	$ (5,569)
Maturities greater than 90 days:
Repayments of commercial paper	0	(2,645)
Total repayments of commercial paper, net	$ (3,984)	$ (8,214)

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details) shares in Millions, $ in Billions	3 Months Ended
	Dec. 30, 2023 USD ($) shares
Stockholders' Equity Note [Abstract]
Number of shares repurchased (in shares) | shares	118
Amount of share repurchases, excluding excise tax | $	$ 20.5

Share-Based Compensation - Rest

Share-Based Compensation - Restricted Stock Unit Activity and Related Information (Details) - Restricted stock units $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Dec. 30, 2023 USD ($) $ / shares shares
Number of Restricted Stock Units
Beginning balance (in shares) | shares	180,247
RSUs granted (in shares) | shares	74,241
RSUs vested (in shares) | shares	(42,490)
RSUs canceled (in shares) | shares	(3,026)
Ending balance (in shares) | shares	208,972
Weighted-Average Grant Date Fair Value Per RSU
Beginning balance (in dollars per share) | $ / shares	$ 135.91
RSUs granted (in dollars per share) | $ / shares	171.58
RSUs vested (in dollars per share) | $ / shares	110.75
RSUs canceled (in dollars per share) | $ / shares	109.05
Ending balance (in dollars per share) | $ / shares	$ 154.09
Aggregate Fair Value
Aggregate fair value of RSUs | $	$ 40,233

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - Restricted stock units - USD ($) $ in Billions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of RSUs as of the respective vesting dates	$ 7.7	$ 6.8
Total unrecognized compensation cost related to RSUs	$ 27.4
Total unrecognized compensation cost related to RSUs, weighted-average recognition period	2 years 10 months 24 days

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Share-Based Compensation Expense and the Related Income Tax Benefit (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-based compensation expense	$ 2,997	$ 2,905
Income tax benefit related to share-based compensation expense	$ (1,235)	$ (1,178)

Segment Information and Geogr_3

Segment Information and Geographic Data - Information by Reportable Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Net sales	$ 119,575	$ 117,154
Operating income	40,373	36,016
Americas
Segment Reporting Information [Line Items]
Net sales	50,430	49,278
Operating income	20,357	17,864
Europe
Segment Reporting Information [Line Items]
Net sales	30,397	27,681
Operating income	12,711	10,017
Greater China
Segment Reporting Information [Line Items]
Net sales	20,819	23,905
Operating income	8,622	10,437
Japan
Segment Reporting Information [Line Items]
Net sales	7,767	6,755
Operating income	3,819	3,236
Rest of Asia Pacific
Segment Reporting Information [Line Items]
Net sales	10,162	9,535
Operating income	$ 4,579	$ 3,851

Segment Information and Geogr_4

Segment Information and Geographic Data - Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	$ 40,373	$ 36,016
Research and development expense	(7,696)	(7,709)
Operating segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	50,088	45,405
Segment reconciling items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Research and development expense	(7,696)	(7,709)
Corporate non-segment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Other corporate expenses, net	$ (2,019)	$ (1,680)